Legend Biotech Corp, referenced on the NASDAQ exchange as LEGN, is a multinational biopharmaceutical company focused on discovering and developing innovative cell therapies for oncology and other illnesses. The company's impressive bioengineering technologies and clinical development expertise place it on the frontier of scientific discovery in the field of cell therapy and biological products for human therapeutic use.
Legend Biotech was originally established in 2014 as the subsidiary of GenScript Biotech Corporation, a global biotech company based in Nanjing, China. Since then, Legend Biotech has flourished, seeking to revolutionize medicine with technology designed to address unmet medical needs.
The company ploughs deep into the domain of CAR-T (Chimeric Antigen Receptor T-cell) therapies, which are treatments that use genetically modified cells from a patient's immune system to target and kill cancer cells. In collaboration with Johnson & Johnson’s Janssen unit, Legend Biotech has made significant progress in the development of its CAR-T cell therapy, particularly in the treatment of multiple myeloma, a blood cancer.
One of the firm's primary candidates is Cilta-cel, a CAR-T cell therapy co-developed with Janssen Biotech for treating relapsed or refractory multiple myeloma. The drug has so far demonstrated promising responses in clinical trials and is proceeding in pre-established strides toward regulatory approval.
Legend Biotech takes pride in fostering a dynamic, diverse, and inclusive culture that values every team member's input and perspective. The company is headquartered in Somerset, New Jersey, USA, with additional functions in California and in China.
The company commands a competitive status in the fast-evolving biotech industry. With their commitment to innovation and relentless pursuit of medical breakthroughs, Legend Biotech stands as a testament to continuous and dogged research in the field of biotechnology. They are geared towards providing effective and transformative solutions to patients by translating basic science into life-saving therapies.
Despite their relatively recent entrance into the market, the strides made by Legend Biotech Corp highlight their potential, strength, and capacity in a highly competitive industry. The company's unwavering dedication to researching and developing novel cell therapies has positioned it as a significant player on the stage of biotechnology and healthcare.